Richard Lipkin
Co-Founder, Co-Chair, and Co-Manager of the Investment Committee

Richard Lipkin is a Co-Founder, Co-Chair, and Co-Manager of the Investment Committee, of the Catalytic Impact Foundation (CIF). He is also a Managing Director of Easton Capital Investment Group, a NYC-based life sciences and healthcare venture capital firm; and a co-Founder and Co-Chair of Princeton Alumni Angels (PAA). Through CIF, he serves as a Board Director of Epivax Therapeutics and Ceretype Neuromedicine, and Board Observer of Deck Therapeutics. Previously, he served as a partner of Commerce Health Ventures, a life sciences and healthcare fund of NewSpring Capital; Laird & Company, a private merchant bank; and other private investment partnerships, including as a biotech analyst and consultant for a Goldman Sachs hedge fund. He also served as Executive Director, Strang Cancer Prevention Center; and Director, International Development, for IDT Corp., including the launch of Net2Phone. He has consulted for DARPA, and served as a writer and editor for Scientific American and Science News, producing more than 400 articles, chapters, and books for many organizations, including National Geographic, Natural History, The Journal of NIH Research, Journal of Neuroscience, Frontiers in Human Neuroscience, The Wilson Quarterly, Smithsonian Books, WNET-13, United Press International, Grolier’s Encyclopedia, and the American Mathematical Society; reprinted by Annual Editions, Global Studies, Social Issues Resource Series, the U.S. Information Agency, and recognized in Who’s Who in Science and Engineering and Men of Achievement. He was awarded the American Chemical Society’s Grady-Stack Award, recognizing analysis of basic and applied scientific and medical research. He has studied cognitive and computational neuroscience at Columbia University and the Marine Biological Laboratory in Woods Hole, MA, and served on Columbia University Medical Center’s Health Sciences Advisory Council, Neuroscience Council, and Medical Science and Technology Council. He is a frequent panelist, moderator, judge, mentor and advisor to many companies and impact organizations, active in many not-for-profit, educational, and social progress ventures, and served as Director, Board member, committee member, program overseer, grant reviewer, including in neuroscience and oncology research; served as member of boards, councils, and committees for the Weizmann Institute of Science, the Israel Cancer Research Fund, Rockefeller University, Marine Biological Laboratory, Columbia University, the New York Academy of Sciences, and the Montefiore Medical Center. He is an honors graduate of Princeton University, has an MBA from Columbia Business School, and served as a Senior Staff Associate in Columbia University’s Zuckerman Institute of Mind, Brain, and Behavior. He lives in New York City with his wife and two sons.